MICHELLE PEGO: Open Payments
NPI 1417493750 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 49 payments from 18 companies in 2025. Trend: 2023 $959 · 2024 $811 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $284 |
| AstraZeneca Pharmaceuticals LP | 6 | $149 |
| ABBVIE INC. | 5 | $137 |
| PFIZER INC. | 4 | $100 |
| Astellas Pharma US Inc | 3 | $68 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Lilly USA, LLC | 2 | $45 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
Products named: Ozempic, QULIPTA, AIRSUPRA, PREVNAR 20, Wegovy, Veozah, FARXIGA, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
